The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
Rapid Response Innovation Awards, 2013Alpha-synuclein Picobody: A Novel Blood-Brain Barrier Permeable Diagnostic Ligand for Parkinson's Disease
Objective/Rationale:
The presence of the blood-brain barrier (BBB) has been an insurmountable impediment to successful drug delivery to the central nervous system. To circumvent the BBB... -
Dyskinesia Challenge, 2013Imaging Dyskinesia in People with Parkinson's Disease
Objective/Rationale:
Levodopa-induced dyskinesias are abnormal involuntary movements that may develop with levodopa therapy for Parkinson's disease (PD). Recent studies on pre-clinical... -
LRRK2 Pharmacodynamic Assays, 2013LRRK2-associated Mitochondrial DNA Damage as a Phenotype for Unbiased Screening
Objective/Rationale:
The normal functions of LRRK2 are poorly understood, and the mechanism(s) by which LRRK2 mutations cause PD are unclear. Also, therapeutic development has been hampered by the... -
Biosample and Tissue Resource, 2013Is Dysphagia in Parkinson’s Disease Caused by Lewy Pathology in the Upper Aerodigestive Tract?
Objective/Rationale:
We have recently demonstrated that the nerves supplying the throat are directly affected in Parkinson’s disease (PD) by the same microscopic process that affects the... -
Research Grant, 2013Virtual Research Visits
Objective/Rationale:
The Michael J. Fox Foundation’s Fox Trial Finder is designed to facilitate and increase the participation of individuals with Parkinson’s disease in clinical trials... -
Research Grant, 2013Long-term Cortical Recording in Parkinson’s Disease Patients Using a Totally Implanted Device
Objective/Rationale:
Deep brain stimulation (DBS) of basal ganglia structures is an effective treatment for Parkinson’s disease (PD). However, its mechanism of action is still unclear...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.